Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I

Piter J. Bosma, Namita Roy Chowdhury, Bart G. Goldhoorn, Martin H. Hofker, Ronald P J Oude Elferink, Peter L M Jansen, Jayanta Roy-Chowdhury

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

Crigler-Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin-UDP-glucuronosyltransferase gene complex that encodes two bilirubin-UDP-glucuronosyltransferase isoforms and a phenol-UDP-glucuronosyltransferase isoform in the human liver. The two bilirubin-UDP-glucuronosyltransferase messenger RNAs and the phenol-UDP-glucuronosyltransferase messenger RNA have identical 3′ regions derived from four consecutive exons. The 5′ region of each messenger RNA is unique and is derived from distinct single exons. By screening a human genomic library with probes corresponding to various regions of the messenger RNAs, we have isolated five cosmid clones containing overlapping segments of this large gene complex that spans at least 84 kb of the human genome. To facilitate the amplification of each exon by polymerase chain reaction and their adjacent splice junctions, we have delineated the intron-exon boundaries of the four common region exons and the two single exons that encode the unique regions of the two bilirubin-UDP-glucuronosyltransferase isoforms and have described sequences of the regions flanking each exon. All exons encoding the two bilirubin-UDP-glucuronosyltransferase isoforms and their splice junctions were amplified from the DNA of two control subjects and a Crigler-Najjar syndrome, type I patient. The DNA from the Crigler-Najjar syndrome, type I patient revealed a point mutation in exon 3 (a common region exon) resulting in a stop codon. RNA blot showed that the two bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the CriglerNajjar syndrome, type I patient were of normal length but were reduced in concentration. As expected, the mutation was found in the common region of both bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the patient. The premature stop codon is predicted to encode truncated and inactive bilirubin-UDP-glucuronosyltransferase forms. Bilirubin-UDP-glucuronosyltransferase proteins were not detectable by immunotransblot in the liver of the Crigler-Najjar syndrome, type I patient. The single mutation in a common region exon explains the simultaneous loss of activity of both bilirubin-UDP-glucuronosyltransferase isoforms and marked reduction of UDP-glucuronosyltransferase activity toward phenol.

Original languageEnglish (US)
Pages (from-to)941-947
Number of pages7
JournalHepatology
Volume15
Issue number5
StatePublished - May 1992

Fingerprint

bilirubin glucuronoside glucuronosyltransferase
Crigler-Najjar Syndrome
Exons
Mutation
Genes
Protein Isoforms
Messenger RNA
Liver
Glucuronosyltransferase

ASJC Scopus subject areas

  • Hepatology

Cite this

Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. / Bosma, Piter J.; Chowdhury, Namita Roy; Goldhoorn, Bart G.; Hofker, Martin H.; Oude Elferink, Ronald P J; Jansen, Peter L M; Roy-Chowdhury, Jayanta.

In: Hepatology, Vol. 15, No. 5, 05.1992, p. 941-947.

Research output: Contribution to journalArticle

Bosma, Piter J. ; Chowdhury, Namita Roy ; Goldhoorn, Bart G. ; Hofker, Martin H. ; Oude Elferink, Ronald P J ; Jansen, Peter L M ; Roy-Chowdhury, Jayanta. / Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. In: Hepatology. 1992 ; Vol. 15, No. 5. pp. 941-947.
@article{8d934abe7ae9423181e7ec5e6e045284,
title = "Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I",
abstract = "Crigler-Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin-UDP-glucuronosyltransferase gene complex that encodes two bilirubin-UDP-glucuronosyltransferase isoforms and a phenol-UDP-glucuronosyltransferase isoform in the human liver. The two bilirubin-UDP-glucuronosyltransferase messenger RNAs and the phenol-UDP-glucuronosyltransferase messenger RNA have identical 3′ regions derived from four consecutive exons. The 5′ region of each messenger RNA is unique and is derived from distinct single exons. By screening a human genomic library with probes corresponding to various regions of the messenger RNAs, we have isolated five cosmid clones containing overlapping segments of this large gene complex that spans at least 84 kb of the human genome. To facilitate the amplification of each exon by polymerase chain reaction and their adjacent splice junctions, we have delineated the intron-exon boundaries of the four common region exons and the two single exons that encode the unique regions of the two bilirubin-UDP-glucuronosyltransferase isoforms and have described sequences of the regions flanking each exon. All exons encoding the two bilirubin-UDP-glucuronosyltransferase isoforms and their splice junctions were amplified from the DNA of two control subjects and a Crigler-Najjar syndrome, type I patient. The DNA from the Crigler-Najjar syndrome, type I patient revealed a point mutation in exon 3 (a common region exon) resulting in a stop codon. RNA blot showed that the two bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the CriglerNajjar syndrome, type I patient were of normal length but were reduced in concentration. As expected, the mutation was found in the common region of both bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the patient. The premature stop codon is predicted to encode truncated and inactive bilirubin-UDP-glucuronosyltransferase forms. Bilirubin-UDP-glucuronosyltransferase proteins were not detectable by immunotransblot in the liver of the Crigler-Najjar syndrome, type I patient. The single mutation in a common region exon explains the simultaneous loss of activity of both bilirubin-UDP-glucuronosyltransferase isoforms and marked reduction of UDP-glucuronosyltransferase activity toward phenol.",
author = "Bosma, {Piter J.} and Chowdhury, {Namita Roy} and Goldhoorn, {Bart G.} and Hofker, {Martin H.} and {Oude Elferink}, {Ronald P J} and Jansen, {Peter L M} and Jayanta Roy-Chowdhury",
year = "1992",
month = "5",
language = "English (US)",
volume = "15",
pages = "941--947",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I

AU - Bosma, Piter J.

AU - Chowdhury, Namita Roy

AU - Goldhoorn, Bart G.

AU - Hofker, Martin H.

AU - Oude Elferink, Ronald P J

AU - Jansen, Peter L M

AU - Roy-Chowdhury, Jayanta

PY - 1992/5

Y1 - 1992/5

N2 - Crigler-Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin-UDP-glucuronosyltransferase gene complex that encodes two bilirubin-UDP-glucuronosyltransferase isoforms and a phenol-UDP-glucuronosyltransferase isoform in the human liver. The two bilirubin-UDP-glucuronosyltransferase messenger RNAs and the phenol-UDP-glucuronosyltransferase messenger RNA have identical 3′ regions derived from four consecutive exons. The 5′ region of each messenger RNA is unique and is derived from distinct single exons. By screening a human genomic library with probes corresponding to various regions of the messenger RNAs, we have isolated five cosmid clones containing overlapping segments of this large gene complex that spans at least 84 kb of the human genome. To facilitate the amplification of each exon by polymerase chain reaction and their adjacent splice junctions, we have delineated the intron-exon boundaries of the four common region exons and the two single exons that encode the unique regions of the two bilirubin-UDP-glucuronosyltransferase isoforms and have described sequences of the regions flanking each exon. All exons encoding the two bilirubin-UDP-glucuronosyltransferase isoforms and their splice junctions were amplified from the DNA of two control subjects and a Crigler-Najjar syndrome, type I patient. The DNA from the Crigler-Najjar syndrome, type I patient revealed a point mutation in exon 3 (a common region exon) resulting in a stop codon. RNA blot showed that the two bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the CriglerNajjar syndrome, type I patient were of normal length but were reduced in concentration. As expected, the mutation was found in the common region of both bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the patient. The premature stop codon is predicted to encode truncated and inactive bilirubin-UDP-glucuronosyltransferase forms. Bilirubin-UDP-glucuronosyltransferase proteins were not detectable by immunotransblot in the liver of the Crigler-Najjar syndrome, type I patient. The single mutation in a common region exon explains the simultaneous loss of activity of both bilirubin-UDP-glucuronosyltransferase isoforms and marked reduction of UDP-glucuronosyltransferase activity toward phenol.

AB - Crigler-Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin-UDP-glucuronosyltransferase gene complex that encodes two bilirubin-UDP-glucuronosyltransferase isoforms and a phenol-UDP-glucuronosyltransferase isoform in the human liver. The two bilirubin-UDP-glucuronosyltransferase messenger RNAs and the phenol-UDP-glucuronosyltransferase messenger RNA have identical 3′ regions derived from four consecutive exons. The 5′ region of each messenger RNA is unique and is derived from distinct single exons. By screening a human genomic library with probes corresponding to various regions of the messenger RNAs, we have isolated five cosmid clones containing overlapping segments of this large gene complex that spans at least 84 kb of the human genome. To facilitate the amplification of each exon by polymerase chain reaction and their adjacent splice junctions, we have delineated the intron-exon boundaries of the four common region exons and the two single exons that encode the unique regions of the two bilirubin-UDP-glucuronosyltransferase isoforms and have described sequences of the regions flanking each exon. All exons encoding the two bilirubin-UDP-glucuronosyltransferase isoforms and their splice junctions were amplified from the DNA of two control subjects and a Crigler-Najjar syndrome, type I patient. The DNA from the Crigler-Najjar syndrome, type I patient revealed a point mutation in exon 3 (a common region exon) resulting in a stop codon. RNA blot showed that the two bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the CriglerNajjar syndrome, type I patient were of normal length but were reduced in concentration. As expected, the mutation was found in the common region of both bilirubin-UDP-glucuronosyltransferase messenger RNAs in the liver of the patient. The premature stop codon is predicted to encode truncated and inactive bilirubin-UDP-glucuronosyltransferase forms. Bilirubin-UDP-glucuronosyltransferase proteins were not detectable by immunotransblot in the liver of the Crigler-Najjar syndrome, type I patient. The single mutation in a common region exon explains the simultaneous loss of activity of both bilirubin-UDP-glucuronosyltransferase isoforms and marked reduction of UDP-glucuronosyltransferase activity toward phenol.

UR - http://www.scopus.com/inward/record.url?scp=0026505255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026505255&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 941

EP - 947

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -